HomeCompareNWARF vs JNJ

NWARF vs JNJ: Dividend Comparison 2026

NWARF yields 5.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NWARF wins by $9.2K in total portfolio value
10 years
NWARF
NWARF
● Live price
5.76%
Share price
$1.53
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.2K
Annual income
$832.69
Full NWARF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NWARF vs JNJ

📍 NWARF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNWARFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NWARF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NWARF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NWARF
Annual income on $10K today (after 15% tax)
$490.00/yr
After 10yr DRIP, annual income (after tax)
$707.79/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NWARF beats the other by $4.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NWARF + JNJ for your $10,000?

NWARF: 50%JNJ: 50%
100% JNJ50/50100% NWARF
Portfolio after 10yr
$24.6K
Annual income
$830.24/yr
Blended yield
3.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NWARF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NWARF buys
0
JNJ buys
0
No recent congressional trades found for NWARF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNWARFJNJ
Forward yield5.76%3.36%
Annual dividend / share$0.09$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$29.2K$20.0K
Annual income after 10y$832.69$827.78
Total dividends collected$7.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NWARF vs JNJ ($10,000, DRIP)

YearNWARF PortfolioNWARF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,276$576.47$10,676$355.77+$600.00NWARF
2$12,673$607.53$11,407$389.39+$1.3KNWARF
3$14,199$638.12$12,198$426.53+$2.0KNWARF
4$15,861$668.15$13,056$467.62+$2.8KNWARF
5$17,668$697.53$13,987$513.12+$3.7KNWARF
6$19,631$726.20$14,998$563.56+$4.6KNWARF
7$21,760$754.10$16,098$619.52+$5.7KNWARF
8$24,064$781.17$17,295$681.69+$6.8KNWARF
9$26,556$807.38$18,599$750.82+$8.0KNWARF
10$29,248$832.69$20,022$827.78+$9.2KNWARF

NWARF vs JNJ: Complete Analysis 2026

NWARFStock

Norwegian Air Shuttle ASA, together with its subsidiaries, provides scheduled and charter airline services in Norway and internationally. As of December 31, 2021, the company operated a fleet of 70 aircraft. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.

Full NWARF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NWARF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NWARF vs SCHDNWARF vs JEPINWARF vs ONWARF vs KONWARF vs MAINNWARF vs ABBVNWARF vs MRKNWARF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.